Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Rating) – Research analysts at HC Wainwright issued their Q1 2023 earnings per share (EPS) estimates for Yield10 Bioscience in a report issued on Wednesday, March 15th. HC Wainwright analyst A. Dayal anticipates that the specialty chemicals company will post earnings of ($0.45) per share for the quarter. HC Wainwright also issued estimates for Yield10 Bioscience’s Q2 2023 earnings at ($0.50) EPS, Q3 2023 earnings at ($0.33) EPS, Q4 2023 earnings at ($0.36) EPS and FY2027 earnings at $0.12 EPS.
Yield10 Bioscience Trading Up 11.7 %
Shares of Yield10 Bioscience stock opened at $2.58 on Thursday. The stock has a market capitalization of $12.80 million, a price-to-earnings ratio of -0.96 and a beta of 1.75. Yield10 Bioscience has a twelve month low of $1.63 and a twelve month high of $6.12. The business’s 50 day simple moving average is $3.18 and its 200-day simple moving average is $2.82.
Hedge Funds Weigh In On Yield10 Bioscience
About Yield10 Bioscience
Yield10 Bioscience, Inc operates as an agricultural bioscience company. It focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P.
- Get a free copy of the StockNews.com research report on Yield10 Bioscience (YTEN)
- Don’t Miss Out: $2 Trillion Could be Headed to the Banking Sector
- A Weakening Economy Suggests Caution Before Buying Five Below
- Williams-Sonoma: Time To Buy At Rock-Bottom Prices
- Why DraftKings Could Keep Outperforming in 2023
- Charles Schwab And The Safest 30% You Can Make This Year
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.